Welcome to the international HTA database

Showing [21797 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of uterine adhesions
2016	NIHR Health Technology Assessment programme	Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation
2012	HAYES, Inc.	Septin 9 (SEPT9) methylation analysis for colorectal cancer
2006	National Institute for Health and Care Excellence (NICE)	Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2012	Blue Cross Blue Shield Association (BCBS)	Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2010	National Institute for Health and Care Excellence (NICE)	SeQuent Please balloon catheter for in-stent coronary restenosis
2005	Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ)	Sequential antibiotic treatment of pneumonia - primary research
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Seralite® for multiple myeloma and other B cell dyscrasias
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Serenity System® to treat tinnitus
2002	Blue Cross Blue Shield Association (BCBS)	Serial endpoint testing for the diagnosis and treatment of allergic disorders
2011	HAYES, Inc.	Serial Transverse Enteroplasty (STEP) for short bowel syndrome
2017	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with HPV vaccination
2019	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with influenza vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with oral cholera vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with yellow fever vaccination
2003	HAYES, Inc.	Serologic assays for the diagnosis and management of inflammatory bowel disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2002	Institute for Clinical Systems Improvement (ICSI)	Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2006	HAYES, Inc.	Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2012	Agency for Healthcare Research and Quality (AHRQ)	Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias
2003	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - systematic review, expert panel
2004	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - update of previous report
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2008	Quality Improvement Scotland (NHS QIS )	Service delivery organisation for acute low back pain
2003	Adelaide Health Technology Assessment (AHTA)	Service improvement tools for the prevention, diagnosis and management of chronic diseases
2015	NIHR Health Services and Delivery Research programme	Service user engagement and health service reconfiguration: a rapid evidence synthesis
2000	Israel Center for Technology Assessment in Health Care (ICTAHC)	Setting priorities for the adoption of health technologies on a national level - the Israeli experience
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer in patients with end-stage renal disease: a systematic review and economic evaluation
2012	Institute for Clinical Evaluative Sciences (ICES)	Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2013	Health Quality Ontario (HQO)	Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Sex change surgery - expert panel. IPE-02/i
2004	HAYES, Inc.	Sex reassignment surgery and associated therapies for the treatment of gender identity disorder
2014	HAYES, Inc.	Sex reassignment surgery for the treatment of gender dysphoria
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sexual Assault Nurse Evaluation (SANE) rape crisis procedure: clinical effectiveness and guidelines
2010	Institute of Health Economics (IHE)	Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2013	Medical Services Advisory Committee (MSAC)	Sexual health medicine consultation items
2015	NIHR Public Health Research (PHR) programme	Sexual health promotion for young people delivered via digital media: a scoping review
2004	Agency for Healthcare Research and Quality (AHRQ)	Sexuality and reproductive health following spinal cord injury
2022	Agency for Care Effectiveness (ACE)	SGLT2 inhibitors for treating heart failure with reduced ejection fraction and chronic kidney disease
1997	VA Technology Assessment Program (VATAP)	Shared decision-making programs: a descriptive analysis of experience with shared decision-making programs in VA. A systematic review: assessing the effectiveness of shared decision-making programs for prostate care
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Shared governance for nursing assistants and other ancillary medical staff in the hospital setting
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Shared medical appointments (SMAs) for type 2 diabetes management
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Sheffield Support Snood for neurodegenerative conditions
2004	VA Technology Assessment Program (VATAP)	Shelf-life of stored sterilized materials: should VHA adopt expiration dating or event-related outdating?
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Shiftwork and health risks: possibilities for prevention
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2022	NIHR Health Technology Assessment programme	Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022	NIHR Health Technology Assessment programme	Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome; the PREDNOS 2 study
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short- and long-term use of benzodiazepines in patients with generalized anxiety disorder: a review of guidelines
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting agents for procedural sedation and analgesia in Canadian emergency departments: a review of clinical outcomes and economic evaluation
2007	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2006	National Institute for Health and Care Excellence (NICE)	Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery
2013	Health Quality Ontario (HQO)	Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review
2005	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	Should one or two embryos be transferred in IVF? A health technology assessment
2000	Centre for Clinical Effectiveness (CCE)	Should prophylatic routine anti-coagulant therapy be used before and after hysterectomies when no other risk factors are known?
2004	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Should the French breast cancer screening programme be extended to women aged 40-49? Update
2002	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions?
2002	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis?
2002	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C?
2006	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the McGill University Health Centre use safety devices to reduce needlestick injuries associated with intravascular infusions?
2003	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the MUHC approve the use of colorectal stents?
2003	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the MUHC approve the video capsule endoscopy system in the diagnosis of small bowel abnormalities?
2003	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Should the MUHC use low-molecular-weight heparin in inpatient treatment of deep vein thrombosis with or without pulmonary embolism?
2000	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Shoulder arthroplasty in indications for degenerative or traumatologic processes. IPE-00/25 (Public report)
2010	National Institute for Health and Care Excellence (NICE)	Shoulder resurfacing arthroplasty
2010	HAYES, Inc.	Shoulder resurfacing for treatment of arthritis and degenerative joint disease
2001	Centre for Clinical Effectiveness (CCE)	Shoulder supports in patients with hypotonicity following stroke
2012	HAYES, Inc.	Sialoendoscopy for salivary gland stones
2001	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Sibutramine
2004	The Swedish Council on Health Technology Assessment (SBU)	Sickness absence - causes, consequences and practices
2004	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Sickness certification: current situation and proposals for improving practice
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2011	HAYES, Inc.	Signal-Averaged Electrocardiogram (SAECG) to identify risk of ventricular tachyarrhythmias and sudden cardiac death
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sildenafil (Revatio) 10mg/ml powder for oral suspension
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sildenafil (Revatio®) for the treatment of pulmonary arterial hypertension (WHO functional class II or III) to improve exercise capacity
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sildenafil citrate (Revatio®) solution
2004	NIHR Horizon Scanning Centre (NIHR HSC)	Sildenafil citrate for adult pulmonary arterial hypertension - horizon scanning review
2002	HAYES, Inc.	Sildenafil citrate for sexual dysfunction
2002	NIHR Horizon Scanning Centre (NIHR HSC)	Sildenafil for female sexual arousal disorder - horizon scanning review
1998	West Midlands Health Technology Assessment Collaboration (WMHTAC)	Sildenafil: an oral drug for the treatment of male erectile dysfunction
1996	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Silicon breast implants
2023	Belgian Health Care Knowledge Centre (KCE)	Silicone adhesive multilayer foam dressings to prevent hospital-acquired pressure ulcers: a Belgian RCT-based economic evaluation
1996	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Silicone gel breast implants
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Silodosin for benign prostatic hyperplasia
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Silver coated dressings for prevention of surgical site infections in cardiac surgery patients
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2008	HAYES, Inc.	Silver-coated urinary catheters for prevention of urinary tract infections
2007	HAYES, Inc.	Silver-coated urinary catheters for prevention of urinary tract infections
2020	NIHR Health Technology Assessment programme	Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
2005	Adelaide Health Technology Assessment (AHTA)	SilverHawk (TM) Peripheral Plaque Excision System: percutaneous peripheral atherectomy for patients with peripheral vascular disease